BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29903353)

  • 1. Cardiovascular Outcomes Reported in Hemodialysis Trials.
    O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Roy D; Herrington WG; Herzog CA; Jafar T; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Webster AC; Wheeler DC
    J Am Coll Cardiol; 2018 Jun; 71(24):2802-2810. PubMed ID: 29903353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop.
    Tong A; Manns B; Hemmelgarn B; Wheeler DC; Evangelidis N; Tugwell P; Crowe S; Van Biesen W; Winkelmayer WC; O'Donoghue D; Tam-Tham H; Shen JI; Pinter J; Larkins N; Youssouf S; Mandayam S; Ju A; Craig JC;
    Am J Kidney Dis; 2017 Jan; 69(1):97-107. PubMed ID: 27497527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.
    Viecelli AK; O'Lone E; Sautenet B; Craig JC; Tong A; Chemla E; Hooi LS; Lee T; Lok C; Polkinghorne KR; Quinn RR; Vachharajani T; Vanholder R; Zuo L; Irish AB; Mori TA; Pascoe EM; Johnson DW; Hawley CM
    Am J Kidney Dis; 2018 Mar; 71(3):382-391. PubMed ID: 29203125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
    Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey.
    Evangelidis N; Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Sautenet B; O'Donoghue D; Tam-Tham H; Youssouf S; Mandayam S; Ju A; Hawley C; Pollock C; Harris DC; Johnson DW; Rifkin DE; Tentori F; Agar J; Polkinghorne KR; Gallagher M; Kerr PG; McDonald SP; Howard K; Howell M; Craig JC;
    Am J Kidney Dis; 2017 Oct; 70(4):464-475. PubMed ID: 28238554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.
    Sautenet B; Tong A; Williams G; Hemmelgarn BR; Manns B; Wheeler DC; Tugwell P; van Biesen W; Winkelmayer WC; Crowe S; Harris T; Evangelidis N; Hawley CM; Pollock C; Johnson DW; Polkinghorne KR; Howard K; Gallagher MP; Kerr PG; McDonald SP; Ju A; Craig JC
    Am J Kidney Dis; 2018 Jul; 72(1):62-74. PubMed ID: 29475768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.
    Viecelli AK; Tong A; O'Lone E; Ju A; Hanson CS; Sautenet B; Craig JC; Manns B; Howell M; Chemla E; Hooi LS; Johnson DW; Lee T; Lok CE; Polkinghorne KR; Quinn RR; Vachharajani T; Vanholder R; Zuo L; Hawley CM;
    Am J Kidney Dis; 2018 May; 71(5):690-700. PubMed ID: 29478866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop.
    O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC;
    Am J Kidney Dis; 2020 Jul; 76(1):109-120. PubMed ID: 32414662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a Core Outcome Measure for Fatigue in Patients on Hemodialysis: A Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop Report.
    Ju A; Unruh M; Davison S; Dapueto J; Dew MA; Fluck R; Germain M; Jassal SV; Obrador G; O'Donoghue D; Josephson MA; Craig JC; Viecelli A; O'Lone E; Hanson CS; Manns B; Sautenet B; Howell M; Reddy B; Wilkie C; Rutherford C; Tong A;
    Am J Kidney Dis; 2018 Jul; 72(1):104-112. PubMed ID: 29551585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular problems in dialysis patients: impact on survival.
    Sidhu MS; Dellsperger KC
    Adv Perit Dial; 2010; 26():47-52. PubMed ID: 21348379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of cardiovascular medications during hemodialysis.
    Tieu A; Leither M; Urquhart BL; Weir MA
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):257-67. PubMed ID: 27023840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and Renal Outcomes Trials-Is There a Difference?
    Raggi P; Boer R; Goodman WG; Kalantar-Zadeh K; Chertow GM; Belozeroff V
    Am J Cardiol; 2015 Sep; 116(6):982-8. PubMed ID: 26198118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals.
    O'Lone E; Howell M; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AY; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC
    Nephrol Dial Transplant; 2020 Oct; 35(10):1761-1769. PubMed ID: 32040154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Am J Kidney Dis; 2014 Jun; 63(6):954-67. PubMed ID: 24434188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials.
    Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ
    Am J Kidney Dis; 2014 Jun; 63(6):968-78. PubMed ID: 24685515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.
    Viecelli AK; Howell M; Tong A; Teixeira-Pinto A; O'Lone E; Ju A; Craig JC; Hooi LS; Lee T; Lok CE; Polkinghorne KR; Quinn RR; Vachharajani TJ; Vanholder R; Zuo L; Tordoir J; Pecoits-Filho R; Yuo T; Kopperschmidt P; Smith R; Irish AB; Mori TA; Pascoe EM; Johnson DW; Hawley CM
    Nephrol Dial Transplant; 2020 Apr; 35(4):657-668. PubMed ID: 31369099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.